NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
NovelStem International Shareholders Equity (Quarterly) : -2.032M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.032M |
| March 31, 2026 | -1.947M |
| December 31, 2025 | -2.142M |
| September 30, 2025 | -2.052M |
| June 30, 2025 | -1.975M |
| March 31, 2025 | -5.343M |
| December 31, 2024 | -5.144M |
| September 30, 2024 | -4.990M |
| June 30, 2024 | -2.535M |
| March 31, 2024 | -2.241M |
| December 31, 2023 | -1.952M |
| September 30, 2023 | -2.015M |
| June 30, 2023 | -0.9353M |
| March 31, 2023 | 1.679M |
| December 31, 2022 | 1.933M |
| September 30, 2022 | 1.737M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 629.98M |
| Kezar Life Sciences, Inc. | 65.24M |
| Protara Therapeutics, Inc. | 161.31M |
| Clene, Inc. | -24.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0647M |
| Total Liabilities (Quarterly) | 2.097M |
| Debt to Equity Ratio | -0.8748 |
| Current Ratio | 0.0309 |
| Net Debt Paydown Yield | 88.07% |